🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 9 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/02/1998 39,00 39,00 35,63 39,00 -1,89% 8,65% 6.950
04/02/1998 39,75 40,50 38,63 39,75 +0,00% 4,72% 5.067
03/02/1998 40,50 40,50 39,75 39,75 -1,85% 1,85% 1.017
02/02/1998 39,75 41,25 39,38 40,50 +1,89% 4,72% 7.517
30/01/1998 39,75 40,50 39,00 39,75 -0,24% 3,77% 4.433
29/01/1998 40,88 41,63 39,00 39,84 -4,28% 6,42% 2.550
28/01/1998 42,00 42,00 40,50 41,63 -2,63% 3,57% 1.500
27/01/1998 42,00 42,75 42,00 42,75 +3,64% 1,79% 2.300
26/01/1998 40,88 42,75 40,88 41,25 -3,51% 4,59% 3.017
23/01/1998 42,00 43,50 40,50 42,75 -1,72% 7,14% 7.067
22/01/1998 41,25 44,25 41,25 43,50 +5,45% 7,27% 4.517
21/01/1998 39,75 41,63 39,75 41,25 +1,85% 4,72% 4.767
20/01/1998 38,63 40,50 38,63 40,50 +0,93% 4,85% 3.550
16/01/1998 39,75 40,50 39,75 40,13 +0,94% 1,89% 1.800
15/01/1998 40,88 40,88 39,75 39,75 -0,93% 2,75% 2.900
14/01/1998 39,75 41,25 39,38 40,13 +1,90% 4,72% 4.633
13/01/1998 39,38 41,25 39,38 39,38 -4,55% 4,76% 1.367
12/01/1998 41,25 41,25 39,00 41,25 -0,90% 5,45% 5.317
09/01/1998 38,63 41,63 38,63 41,63 +5,71% 7,77% 5.433
08/01/1998 42,75 42,75 37,88 39,38 -7,89% 11,40% 13.383
07/01/1998 44,25 44,25 42,75 42,75 +0,00% 3,39% 1.450
06/01/1998 41,25 43,50 41,25 42,75 +0,00% 5,45% 2.683
05/01/1998 40,88 42,75 39,00 42,75 +4,59% 9,17% 5.667
02/01/1998 40,88 42,00 40,88 40,88 +0,00% 2,75% 617
31/12/1997 40,13 42,00 40,13 40,88 +1,87% 4,67% 4.583
30/12/1997 41,63 41,63 40,13 40,13 -3,60% 3,60% 2.133
29/12/1997 41,63 41,63 40,50 41,63 +2,78% 2,70% 2.717
26/12/1997 41,63 42,38 40,50 40,50 -3,57% 4,50% 3.567
24/12/1997 42,00 42,38 42,00 42,00 -6,67% 0,89% 1.967
23/12/1997 43,50 45,00 42,38 45,00 +5,26% 6,03% 4.167